• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effectiveness of BNT162b2 against COVID-19 in adolescents.

作者信息

Powell Annabel A, Kirsebom Freja, Stowe Julia, McOwat Kelsey, Saliba Vanessa, Ramsay Mary E, Lopez-Bernal Jamie, Andrews Nick, Ladhani Shamez N

机构信息

UK Health Security Agency, London, UK.

UK Health Security Agency, London, UK; NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene & Tropical Medicine, London, UK.

出版信息

Lancet Infect Dis. 2022 May;22(5):581-583. doi: 10.1016/S1473-3099(22)00177-3. Epub 2022 Mar 21.

DOI:10.1016/S1473-3099(22)00177-3
PMID:35325619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8937250/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08f/8937250/61a2c78d31af/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08f/8937250/61a2c78d31af/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d08f/8937250/61a2c78d31af/gr1_lrg.jpg

相似文献

1
Effectiveness of BNT162b2 against COVID-19 in adolescents.BNT162b2对青少年新冠病毒肺炎的有效性
Lancet Infect Dis. 2022 May;22(5):581-583. doi: 10.1016/S1473-3099(22)00177-3. Epub 2022 Mar 21.
2
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.在奥密克戎毒株占主导期间，既往BNT162b2型新冠疫苗接种与儿童及青少年有症状的新冠病毒感染之间的关联
JAMA. 2022 Jun 14;327(22):2210-2219. doi: 10.1001/jama.2022.7493.
3
Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents.BNT162b2疫苗对青少年Delta变异株的有效性
N Engl J Med. 2021 Nov 25;385(22):2101-2103. doi: 10.1056/NEJMc2114290. Epub 2021 Oct 20.
4
Long-term Effectiveness Associated With the BNT162b2 Vaccine Against SARS-CoV-2 Infection Among Adolescents in South Korea.韩国青少年中 BNT162b2 疫苗针对 SARS-CoV-2 感染的长期有效性。
JAMA Netw Open. 2022 Aug 1;5(8):e2227205. doi: 10.1001/jamanetworkopen.2022.27205.
5
The Effectiveness of the Two-Dose BNT162b2 Vaccine: Analysis of Real-World Data.两剂 BNT162b2 疫苗的有效性：真实世界数据分析。
Clin Infect Dis. 2022 Feb 11;74(3):472-478. doi: 10.1093/cid/ciab438.
6
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022.辉瑞-生物科技 BNT162b2 mRNA 疫苗预防非免疫功能低下 5-17 岁儿童和青少年与 COVID-19 相关的急诊和紧急护理就诊及住院的有效性 - VISION 网络，10 个州，2021 年 4 月-2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Mar 4;71(9):352-358. doi: 10.15585/mmwr.mm7109e3.
7
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.智利科兴和国药疫苗接种后动态 IgG 血清阳性率：哨点监测研究。
Lancet Infect Dis. 2022 Jan;22(1):56-63. doi: 10.1016/S1473-3099(21)00479-5. Epub 2021 Sep 9.
8
Humoral and cellular immune responses to Pfizer-BioNTech BNT162b2 SARS-CoV-2 vaccine in adolescents with liver transplantation: Single center experience.青少年肝移植患者对辉瑞-生物科技 BNT162b2 SARS-CoV-2 疫苗的体液和细胞免疫反应：单中心经验。
Front Immunol. 2022 Nov 23;13:1049188. doi: 10.3389/fimmu.2022.1049188. eCollection 2022.
9
Evaluation of BNT162b2 Vaccine Effectiveness in Galicia, Northwest Spain.西班牙西北部加利西亚地区评估 BNT162b2 疫苗的有效性。
Int J Environ Res Public Health. 2022 Mar 29;19(7):4039. doi: 10.3390/ijerph19074039.
10
Real-world effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection among adolescents (12 to 17-year-olds) in Malaysia.马来西亚青少年（12 至 17 岁）中 BNT162b2 疫苗预防 SARS-CoV-2 感染的真实世界效果。
Int J Infect Dis. 2022 Aug;121:55-57. doi: 10.1016/j.ijid.2022.04.053. Epub 2022 Apr 30.

引用本文的文献

1
BNT162b2 COVID-19 vaccination uptake, safety, effectiveness, and waning in children and young people aged 5-11 years in Scotland.苏格兰5至11岁儿童和青少年接种BNT162b2新冠疫苗的情况、安全性、有效性及免疫效果减弱情况
J Glob Health. 2025 Aug 29;15:04250. doi: 10.7189/jogh.15.04250.
2
Intensity of public health and social measures are associated with effectiveness of SARS-CoV-2 vaccine in test-negative study.在阴性对照研究中，公共卫生和社会措施的强度与SARS-CoV-2疫苗的有效性相关。
medRxiv. 2025 May 8:2025.05.08.25327221. doi: 10.1101/2025.05.08.25327221.
3
How do large-scale population studies inform vaccine evaluations in England?

本文引用的文献

1
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.Covid-19 疫苗对奥密克戎（B.1.1.529）变异株的有效性。
N Engl J Med. 2022 Apr 21;386(16):1532-1546. doi: 10.1056/NEJMoa2119451. Epub 2022 Mar 2.
2
Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa.BNT162b2疫苗在南非针对奥密克戎变异株的有效性
N Engl J Med. 2022 Feb 3;386(5):494-496. doi: 10.1056/NEJMc2119270. Epub 2021 Dec 29.
3
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England.
大规模人口研究如何为英国的疫苗评估提供信息？
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxaf006.
4
Prior infections and effectiveness of SARS-CoV-2 vaccine in test-negative studies: a systematic review and meta-analysis.SARS-CoV-2疫苗在检测阴性研究中的既往感染情况及有效性：一项系统评价和荟萃分析
Am J Epidemiol. 2024 Dec 2;193(12):1868-1881. doi: 10.1093/aje/kwae142.
5
Placental transfer dynamics and durability of maternal COVID-19 vaccine-induced antibodies in infants.新冠病毒感染孕产妇疫苗诱导抗体在婴儿体内的胎盘转运动力学及持续性
iScience. 2024 Feb 20;27(3):109273. doi: 10.1016/j.isci.2024.109273. eCollection 2024 Mar 15.
6
Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives.严重儿童 COVID-19：从临床和免疫病理生理学角度的综述。
World J Pediatr. 2024 Apr;20(4):307-324. doi: 10.1007/s12519-023-00790-y. Epub 2024 Feb 6.
7
Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines.对与新冠病毒变异株适配mRNA疫苗相关常见误解的回应。
Vaccines (Basel). 2024 Jan 6;12(1):57. doi: 10.3390/vaccines12010057.
8
Evaluation of SARS-CoV-2 infection risks after primary vaccination with BNT162b2, BBIBP-CorV, or ChAdOx1-nCOV-19 and after homologous and heterologous booster vaccinations with these vaccines and evaluation of SARS-CoV-2 reinfection profiles.评估接种BNT162b2、BBIBP-CorV或ChAdOx1-nCOV-19进行初次疫苗接种后，以及使用这些疫苗进行同源和异源加强接种后的新型冠状病毒2感染风险，并评估新型冠状病毒再次感染情况。
Biomedicine (Taipei). 2023 Sep 1;13(3):31-48. doi: 10.37796/2211-8039.1412. eCollection 2023.
9
Pfizer-BioNTech mRNA Vaccine Protection among Children and Adolescents Aged 12-17 Years against COVID-19 Infection in Qatar.辉瑞-生物科技mRNA疫苗对卡塔尔12至17岁儿童和青少年预防新冠病毒感染的效果
Vaccines (Basel). 2023 Sep 25;11(10):1522. doi: 10.3390/vaccines11101522.
10
Factors associated with COVID-19 vaccine uptake in adolescents: a national cross-sectional study, August 2021-January 2022, England.与青少年接种 COVID-19 疫苗相关的因素：2021 年 8 月至 2022 年 1 月期间，英格兰的一项全国性横断面研究。
BMJ Open. 2023 Sep 29;13(9):e071707. doi: 10.1136/bmjopen-2023-071707.
英格兰延长 COVID-19 疫苗接种计划的血清学反应和疫苗效力。
Nat Commun. 2021 Dec 10;12(1):7217. doi: 10.1038/s41467-021-27410-5.
4
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021.辉瑞-BioNTech mRNA 疫苗对 12-18 岁人群因 COVID-19 住院的有效性-美国，2021 年 6 月至 9 月。
MMWR Morb Mortal Wkly Rep. 2021 Oct 22;70(42):1483-1488. doi: 10.15585/mmwr.mm7042e1.
5
Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021.2021 年以色列 SARS-CoV-2 德尔塔变异株感染爆发期间 BNT162b2 疫苗在青少年中的有效性。
Emerg Infect Dis. 2021 Nov;27(11):2919-2922. doi: 10.3201/eid2711.211886. Epub 2021 Sep 27.
6
Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents.mRNA-1273 新型冠状病毒疫苗在青少年中的评估。
N Engl J Med. 2021 Dec 9;385(24):2241-2251. doi: 10.1056/NEJMoa2109522. Epub 2021 Aug 11.
7
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.辉瑞-BioNTech 新冠疫苗在青少年中的安全性、免疫原性和有效性。
N Engl J Med. 2021 Jul 15;385(3):239-250. doi: 10.1056/NEJMoa2107456. Epub 2021 May 27.